The Precision Medicine Company Developing microbiome-based predictive diagnostic and companion therapeutic products to enable safer and more efficacious drug therapies AlphaBiomics initiates collaboration with Amsterdam University Medical Centers.Read more here. The Precision Medicine Company Developing microbiome-based predictive diagnostic and companion therapeutic products to enable safer and more efficacious drug therapies Winner of the 2018 European Innovation Quickfire Challenge (read more)